T. Xin

发表

Discovery and characterization of AZD9272 and AZD6538-Two novel mGluR5 negative allosteric modulators selected for clinical development.

P. Raboisson, David Wensbo, A. Slassi, 2012, Bioorganic & medicinal chemistry letters.

1-(Bicyclopiperazinyl)ethylindoles and 1-(homopiperazinyl)ethyl-indoles as highly selective and potent 5-HT(7) receptor ligands.

N. Maclean, A. Slassi, M. Isaac, 2002, Bioorganic & medicinal chemistry letters.

5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists.

N. Maclean, A. Slassi, S. Rakhit, 2000, Bioorganic & medicinal chemistry letters.

Dibenzo[1,6]naphthyridindiones as modified quinolone antibacterials

S. Sabatini, O. Tabarrini, V. Cecchetti, 1998 .

Synthesis and antibacterial evaluation of [1,3]benzothiazino[3,2-a]quinoline- and [3,1]benzothiazino[1,2-a]quinoline-6-carboxylic acid derivatives.

G. Cruciani, O. Tabarrini, V. Cecchetti, 1997, Bioorganic & medicinal chemistry.

Potent 6-desfluoro-8-methylquinolones as new lead compounds in antibacterial chemotherapy.

M. Palumbo, O. Tabarrini, V. Cecchetti, 1996, Journal of medicinal chemistry.

The Rh(ii)-catalyzed formal N-S bond insertion reaction of aryldiazoacetates into N-phenyl-sulfenyl phthalimide.

Hongbin Sun, T. Xin, Zhuang Song, 2016, Chemical communications.

Studies on 6-aminoquinolones: synthesis and antibacterial evaluation of 6-amino-8-methylquinolones.

O. Tabarrini, V. Cecchetti, A. Fravolini, 1996, Journal of medicinal chemistry.

Dibenzo[1,6]naphthyridinediones as Modified Quinolone Antibacterials.

S. Sabatini, O. Tabarrini, V. Cecchetti, 1999 .

Recent progress in 5-HT7 receptors: potential treatment of central and peripheral nervous system diseases

Tao Xin, A. Slassi, M. Isaac, 2004 .

Design, synthesis and biological activity of novel dimethyl-{2-[6-substituted-indol-1-yl]-ethyl}-amine as potent, selective, and orally-Bioavailable 5-HT1D agonists

N. Maclean, L. Edwards, M. Isaac, 2003 .